-
Insurers flee healthcare markets amid open enrollmentIn the Spotlight The moves could leave ACA enrollees vulnerable heading into 2027
In the Spotlight -
A new framework reveals the stages of women’s heart healthThe Explainer Doctors now have guidance for earlier intervention in girls’ and women’s cardiovascular health
The Explainer -
Dementia cases to double by 2050 amid aging populationsThe Explainer Researchers analyzed data from 22 studies across the world
The Explainer -
What is ‘circadian depression’?The Explainer Scientists suggest one in four people with depression could fall into new subtype linked to a disrupted body clock
The Explainer -
Pneumonic plague: the suspected death and outbreak in RussiaThe Explainer Numerous people have been quarantined as a result of the disease
The Explainer -
A surgeon shortage creates challenges in rural communitiesThe Explainer Over a third of counties in the U.S. reportedly have no general surgeons
The Explainer -
White House ousts 760K from ACA, claiming fraudSpeed Read Vice President JD Vance said those removed were “phantom people” and “real people who just don’t meet the eligibility requirements”
Speed Read -
AI may have cracked the antiaging codeIn the Spotlight An AI-discovered drug could help slow the aging process
In the Spotlight -
Letters ‘refute’ RFK Jr’s Samoa vaccine testimonySpeed Read The HHS secretary once said his trip to Samoa was unrelated to vaccines
Speed Read -
FDA approves landmark pancreatic cancer drugSpeed Read A clinical trial saw patients on the drug live a median of 13.2 months
Speed Read -
DEI clashes lead to funding cuts for Alzheimer’s researchThe Explainer At least two major research institutions have been hit with cuts
The Explainer -
A ‘pivotal moment’ for personalised cancer vaccinesThe Explainer Early results from final-stage trial of individualised melanoma jab offer hope of more tailor-made cancer treatments
The Explainer -
Moderna says skin cancer vaccine trial a successSpeed Read The experimental vaccine successfully reduced the recurrence of melanoma, the company said
Speed Read -
Stronger, faster, better: the new mRNA flu vaccineThe explainer The jab may be new and improved
The explainer
